Global Anthrax Vaccines Market Insights and Forecast to 2027

1 Study Coverage

• 1.1 Anthrax Vaccines Product Introduction
• 1.2 Market by Type
  • 1.2.1 Global Anthrax Vaccines Market Size Growth Rate by Type
  • 1.4.2 Live Vaccines
  • 1.4.3 Cell free PA Vaccines
• 1.3 Market by Application
  • 1.3.1 Global Anthrax Vaccines Market Size Growth Rate by Application
  • 1.3.2 Human Use
  • 1.3.3 Animal Use
• 1.4 Study Objectives
• 1.5 Years Considered

2 Executive Summary

• 2.1 Global Anthrax Vaccines Sales Estimates and Forecasts 2016-2027
• 2.2 Global Anthrax Vaccines Revenue Estimates and Forecasts 2016-2027
• 2.3 Global Anthrax Vaccines Revenue by Region: 2016 VS 2021 VS 2027
• 2.4 Global Top Anthrax Vaccines Regions by Sales
  • 2.4.1 Global Top Anthrax Vaccines Regions by Sales (2016-2021)
  • 2.4.2 Global Top Anthrax Vaccines Regions by Sales (2022-2027)
• 2.5 Global Top Anthrax Vaccines Regions by Revenue
  • 2.5.1 Global Top Anthrax Vaccines Regions by Revenue (2016-2021)
  • 2.5.2 Global Top Anthrax Vaccines Regions by Revenue (2022-2027)
• 2.6 North America
• 2.7 Europe
• 2.8 Asia-Pacific
• 2.9 Latin America
• 2.10 Middle East & Africa

3 Competition by Manufacturers

• 3.1 Global Anthrax Vaccines Sales by Manufacturers
  • 3.1.1 Global Top Anthrax Vaccines Manufacturers by Sales (2016-2021)
  • 3.1.2 Global Top Anthrax Vaccines Manufacturers Market Share by Sales (2016-2021)
  • 3.1.3 Global Top 10 and Top 5 Companies by Anthrax Vaccines Sales in 2020
• 3.2 Global Anthrax Vaccines Revenue by Manufacturers
  • 3.2.1 Global Top Anthrax Vaccines Manufacturers by Revenue (2016-2021)
  • 3.2.2 Global Top Anthrax Vaccines Manufacturers Market Share by Revenue (2016-2021)
  • 3.2.3 Global Top 10 and Top 5 Companies by Anthrax Vaccines Revenue in 2020
• 3.3 Global Anthrax Vaccines Sales Price by Manufacturers
• 3.4 Analysis of Competitive Landscape
  • 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Anthrax Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.4.3 Global Anthrax Vaccines Manufacturers Geographical Distribution
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Global Anthrax Vaccines Sales by Type
  • 4.1.1 Global Anthrax Vaccines Historical Sales by Type (2016-2021)
  • 4.1.2 Global Anthrax Vaccines Forecasted Sales by Type (2022-2027)
  • 4.1.3 Global Anthrax Vaccines Sales Market Share by Type (2016-2027)
• 4.2 Global Anthrax Vaccines Revenue by Type
  • 4.2.1 Global Anthrax Vaccines Historical Revenue by Type (2016-2021)
  • 4.2.2 Global Anthrax Vaccines Forecasted Revenue by Type (2022-2027)
  • 4.2.3 Global Anthrax Vaccines Revenue Market Share by Type (2016-2027)
• 4.3 Global Anthrax Vaccines Price by Type
  • 4.3.1 Global Anthrax Vaccines Price by Type (2016-2021)
  • 4.3.2 Global Anthrax Vaccines Price Forecast by Type (2022-2027)

5 Market Size by Application

• 5.1 Global Anthrax Vaccines Sales by Application
  • 5.1.1 Global Anthrax Vaccines Historical Sales by Application (2016-2021)
  • 5.1.2 Global Anthrax Vaccines Forecasted Sales by Application (2022-2027)
  • 5.1.3 Global Anthrax Vaccines Sales Market Share by Application (2016-2027)
• 5.2 Global Anthrax Vaccines Revenue by Application
  • 5.2.1 Global Anthrax Vaccines Historical Revenue by Application (2016-2021)
  • 5.2.2 Global Anthrax Vaccines Forecasted Revenue by Application (2022-2027)
  • 5.2.3 Global Anthrax Vaccines Revenue Market Share by Application (2016-2027)
• 5.3 Global Anthrax Vaccines Price by Application
  • 5.3.1 Global Anthrax Vaccines Price by Application (2016-2021)
  • 5.3.2 Global Anthrax Vaccines Price Forecast by Application (2022-2027)

6 North America

• 6.1 North America Anthrax Vaccines Market Size by Type
  • 6.1.1 North America Anthrax Vaccines Sales by Type (2016-2027)
  • 6.1.2 North America Anthrax Vaccines Revenue by Type (2016-2027)
• 6.2 North America Anthrax Vaccines Market Size by Application
  • 6.2.1 North America Anthrax Vaccines Sales by Application (2016-2027)
  • 6.2.2 North America Anthrax Vaccines Revenue by Application (2016-2027)
• 6.3 North America Anthrax Vaccines Market Size by Country
  • 6.3.1 North America Anthrax Vaccines Sales by Country (2016-2027)
  • 6.3.2 North America Anthrax Vaccines Revenue by Country (2016-2027)
  • 6.3.3 U.S.
  • 6.3.4 Canada

7 Europe

• 7.1 Europe Anthrax Vaccines Market Size by Type
  • 7.1.1 Europe Anthrax Vaccines Sales by Type (2017-2027)
  • 7.1.2 Europe Anthrax Vaccines Revenue by Type (2017-2027)
• 7.2 Europe Anthrax Vaccines Market Size by Application
  • 7.2.1 Europe Anthrax Vaccines Sales by Application (2017-2027)
  • 7.2.2 Europe Anthrax Vaccines Revenue by Application (2017-2027)
• 7.3 Europe Anthrax Vaccines Market Size by Country
  • 7.3.1 Europe Anthrax Vaccines Sales by Country (2017-2027)
  • 7.3.2 Europe Anthrax Vaccines Revenue by Country (2017-2027)
  • 7.3.3 Germany
  • 7.3.4 France
  • 7.3.5 U.K.
  • 7.3.6 Italy
  • 7.3.7 Russia

8 Asia Pacific

• 8.1 Asia Pacific Anthrax Vaccines Market Size by Type
  • 8.1.1 Asia Pacific Anthrax Vaccines Sales by Type (2018-2027)
  • 8.1.2 Asia Pacific Anthrax Vaccines Revenue by Type (2018-2027)
• 8.2 Asia Pacific Anthrax Vaccines Market Size by Application
  • 8.2.1 Asia Pacific Anthrax Vaccines Sales by Application (2018-2027)
  • 8.2.2 Asia Pacific Anthrax Vaccines Revenue by Application (2018-2027)
• 8.3 Asia Pacific Anthrax Vaccines Market Size by Region
  • 8.3.1 Asia Pacific Anthrax Vaccines Sales by Region (2018-2027)
  • 8.3.2 Asia Pacific Anthrax Vaccines Revenue by Region (2018-2027)
  • 8.3.3 China
  • 8.3.4 Japan
  • 8.3.5 South Korea
  • 8.3.6 India
  • 8.3.7 Australia
  • 8.3.8 Taiwan
  • 8.3.9 Indonesia
  • 8.3.10 Thailand
  • 8.3.11 Malaysia
  • 8.3.12 Philippines

9 Latin America

• 9.1 Latin America Anthrax Vaccines Market Size by Type
  • 9.1.1 Latin America Anthrax Vaccines Sales by Type (2019-2027)
  • 9.1.2 Latin America Anthrax Vaccines Revenue by Type (2019-2027)
• 9.2 Latin America Anthrax Vaccines Market Size by Application
  • 9.2.1 Latin America Anthrax Vaccines Sales by Application (2019-2027)
  • 9.2.2 Latin America Anthrax Vaccines Revenue by Application (2019-2027)
• 9.3 Latin America Anthrax Vaccines Market Size by Country
  • 9.3.1 Latin America Anthrax Vaccines Sales by Country (2019-2027)
  • 9.3.2 Latin America Anthrax Vaccines Revenue by Country (2019-2027)
  • 9.3.3 Mexico
  • 9.3.4 Brazil
  • 9.3.5 Argentina

6 Middle East and Africa

• 6.1 Middle East and Africa Anthrax Vaccines Market Size by Type
  • 6.1.1 Middle East and Africa Anthrax Vaccines Sales by Type (2016-2027)
  • 6.1.2 Middle East and Africa Anthrax Vaccines Revenue by Type (2016-2027)
• 6.2 Middle East and Africa Anthrax Vaccines Market Size by Application
  • 6.2.1 Middle East and Africa Anthrax Vaccines Sales by Application (2016-2027)
  • 6.2.2 Middle East and Africa Anthrax Vaccines Revenue by Application (2016-2027)
• 6.3 Middle East and Africa Anthrax Vaccines Market Size by Country
  • 6.3.1 Middle East and Africa Anthrax Vaccines Sales by Country (2016-2027)
  • 6.3.2 Middle East and Africa Anthrax Vaccines Revenue by Country (2016-2027)
  • 6.3.3 Turkey
  • 6.3.4 Saudi Arabia
  • 6.3.5 U.A.E

11 Company Profiles

• 11.1 Emergent BioSolutions
  • 11.1.1 Emergent BioSolutions Corporation Information
  • 11.1.2 Emergent BioSolutions Overview
  • 11.1.3 Emergent BioSolutions Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.1.4 Emergent BioSolutions Anthrax Vaccines Product Description
  • 11.1.5 Emergent BioSolutions Related Developments
• 11.2 Merial
  • 11.2.1 Merial Corporation Information
  • 11.2.2 Merial Overview
  • 11.2.3 Merial Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.2.4 Merial Anthrax Vaccines Product Description
  • 11.2.5 Merial Related Developments
• 11.3 Merck
  • 11.3.1 Merck Corporation Information
  • 11.3.2 Merck Overview
  • 11.3.3 Merck Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.3.4 Merck Anthrax Vaccines Product Description
  • 11.3.5 Merck Related Developments
• 11.4 Zoetis
  • 11.4.1 Zoetis Corporation Information
  • 11.4.2 Zoetis Overview
  • 11.4.3 Zoetis Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.4.4 Zoetis Anthrax Vaccines Product Description
  • 11.4.5 Zoetis Related Developments
• 11.5 Bayer Sanidad Animal
  • 11.5.1 Bayer Sanidad Animal Corporation Information
  • 11.5.2 Bayer Sanidad Animal Overview
  • 11.5.3 Bayer Sanidad Animal Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.5.4 Bayer Sanidad Animal Anthrax Vaccines Product Description
  • 11.5.5 Bayer Sanidad Animal Related Developments
• 11.6 Colorado Serum
  • 11.6.1 Colorado Serum Corporation Information
  • 11.6.2 Colorado Serum Overview
  • 11.6.3 Colorado Serum Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.6.4 Colorado Serum Anthrax Vaccines Product Description
  • 11.6.5 Colorado Serum Related Developments
• 11.7 PharmAthene
  • 11.7.1 PharmAthene Corporation Information
  • 11.7.2 PharmAthene Overview
  • 11.7.3 PharmAthene Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.7.4 PharmAthene Anthrax Vaccines Product Description
  • 11.7.5 PharmAthene Related Developments
• 11.8 Tiankang
  • 11.8.1 Tiankang Corporation Information
  • 11.8.2 Tiankang Overview
  • 11.8.3 Tiankang Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.8.4 Tiankang Anthrax Vaccines Product Description
  • 11.8.5 Tiankang Related Developments
• 11.9 Biogénesis-Bago
  • 11.9.1 Biogénesis-Bago Corporation Information
  • 11.9.2 Biogénesis-Bago Overview
  • 11.9.3 Biogénesis-Bago Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.9.4 Biogénesis-Bago Anthrax Vaccines Product Description
  • 11.9.5 Biogénesis-Bago Related Developments
• 11.10 CAVAC
  • 11.10.1 CAVAC Corporation Information
  • 11.10.2 CAVAC Overview
  • 11.10.3 CAVAC Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.10.4 CAVAC Anthrax Vaccines Product Description
  • 11.10.5 CAVAC Related Developments
• 11.1 Emergent BioSolutions
  • 11.1.1 Emergent BioSolutions Corporation Information
  • 11.1.2 Emergent BioSolutions Overview
  • 11.1.3 Emergent BioSolutions Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.1.4 Emergent BioSolutions Anthrax Vaccines Product Description
  • 11.1.5 Emergent BioSolutions Related Developments
• 11.12 Agrovet
  • 11.12.1 Agrovet Corporation Information
  • 11.12.2 Agrovet Overview
  • 11.12.3 Agrovet Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.12.4 Agrovet Product Description
  • 11.12.5 Agrovet Related Developments
• 11.13 Vecol
  • 11.13.1 Vecol Corporation Information
  • 11.13.2 Vecol Overview
  • 11.13.3 Vecol Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.13.4 Vecol Product Description
  • 11.13.5 Vecol Related Developments
• 11.14 CVCRI
  • 11.14.1 CVCRI Corporation Information
  • 11.14.2 CVCRI Overview
  • 11.14.3 CVCRI Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.14.4 CVCRI Product Description
  • 11.14.5 CVCRI Related Developments
• 11.15 IVPM
  • 11.15.1 IVPM Corporation Information
  • 11.15.2 IVPM Overview
  • 11.15.3 IVPM Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.15.4 IVPM Product Description
  • 11.15.5 IVPM Related Developments
• 11.16 Prondil
  • 11.16.1 Prondil Corporation Information
  • 11.16.2 Prondil Overview
  • 11.16.3 Prondil Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.16.4 Prondil Product Description
  • 11.16.5 Prondil Related Developments
• 11.17 CDV
  • 11.17.1 CDV Corporation Information
  • 11.17.2 CDV Overview
  • 11.17.3 CDV Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.17.4 CDV Product Description
  • 11.17.5 CDV Related Developments
• 11.18 Indian Immunologicals
  • 11.18.1 Indian Immunologicals Corporation Information
  • 11.18.2 Indian Immunologicals Overview
  • 11.18.3 Indian Immunologicals Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.18.4 Indian Immunologicals Product Description
  • 11.18.5 Indian Immunologicals Related Developments
• 11.19 Botswana Vaccine Institute
  • 11.19.1 Botswana Vaccine Institute Corporation Information
  • 11.19.2 Botswana Vaccine Institute Overview
  • 11.19.3 Botswana Vaccine Institute Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.19.4 Botswana Vaccine Institute Product Description
  • 11.19.5 Botswana Vaccine Institute Related Developments
• 11.20 Ceva Santé Animale
  • 11.20.1 Ceva Santé Animale Corporation Information
  • 11.20.2 Ceva Santé Animale Overview
  • 11.20.3 Ceva Santé Animale Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.20.4 Ceva Santé Animale Product Description
  • 11.20.5 Ceva Santé Animale Related Developments
• 11.21 Intervac
  • 11.21.1 Intervac Corporation Information
  • 11.21.2 Intervac Overview
  • 11.21.3 Intervac Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.21.4 Intervac Product Description
  • 11.21.5 Intervac Related Developments
• 11.22 JOVAC
  • 11.22.1 JOVAC Corporation Information
  • 11.22.2 JOVAC Overview
  • 11.22.3 JOVAC Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.22.4 JOVAC Product Description
  • 11.22.5 JOVAC Related Developments

12 Value Chain and Sales Channels Analysis

• 12.1 Anthrax Vaccines Value Chain Analysis
• 12.2 Anthrax Vaccines Key Raw Materials
  • 12.2.1 Key Raw Materials
  • 12.2.2 Raw Materials Key Suppliers
• 12.3 Anthrax Vaccines Production Mode & Process
• 12.4 Anthrax Vaccines Sales and Marketing
  • 12.4.1 Anthrax Vaccines Sales Channels
  • 12.4.2 Anthrax Vaccines Distributors
• 12.5 Anthrax Vaccines Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

• 13.1 Anthrax Vaccines Industry Trends
• 13.2 Anthrax Vaccines Market Drivers
• 13.3 Anthrax Vaccines Market Challenges
• 13.4 Anthrax Vaccines Market Restraints

14 Key Findings in The Global Anthrax Vaccines Study

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Author Details